- Home
- CMMB vs WVVI Comparison
CMMB vs WVVI Comparison
Compare CMMB & WVVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMMB
- WVVI
- Stock Information
- Founded
- CMMB 2004
- WVVI 1983
- Country
- CMMB Israel
- WVVI United States
- Employees
- CMMB N/A
- WVVI N/A
- Industry
- CMMB Biotechnology: Pharmaceutical Preparations
- WVVI Beverages (Production/Distribution)
- Sector
- CMMB Health Care
- WVVI Consumer Staples
- Exchange
- CMMB Nasdaq
- WVVI Nasdaq
- Market Cap
- CMMB 22.0M
- WVVI 20.4M
- IPO Year
- CMMB N/A
- WVVI N/A
- Fundamental
- Price
- CMMB $2.83
- WVVI $4.57
- Analyst Decision
- CMMB Strong Buy
- WVVI
- Analyst Count
- CMMB 2
- WVVI 0
- Target Price
- CMMB $26.50
- WVVI N/A
- AVG Volume (30 Days)
- CMMB 141.5K
- WVVI 3.7K
- Earning Date
- CMMB 11-13-2025
- WVVI 11-11-2025
- Dividend Yield
- CMMB N/A
- WVVI N/A
- EPS Growth
- CMMB N/A
- WVVI N/A
- EPS
- CMMB N/A
- WVVI N/A
- Revenue
- CMMB N/A
- WVVI $38,384,350.00
- Revenue This Year
- CMMB N/A
- WVVI N/A
- Revenue Next Year
- CMMB N/A
- WVVI N/A
- P/E Ratio
- CMMB N/A
- WVVI N/A
- Revenue Growth
- CMMB N/A
- WVVI N/A
- 52 Week Low
- CMMB $2.71
- WVVI $3.17
- 52 Week High
- CMMB $9.84
- WVVI $7.18
- Technical
- Relative Strength Index (RSI)
- CMMB 21.60
- WVVI 46.63
- Support Level
- CMMB $2.96
- WVVI $4.80
- Resistance Level
- CMMB $3.09
- WVVI $5.09
- Average True Range (ATR)
- CMMB 0.21
- WVVI 0.21
- MACD
- CMMB 0.00
- WVVI 0.05
- Stochastic Oscillator
- CMMB 11.26
- WVVI 33.31
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101, treating rare fibrotic conditions.
About WVVI Willamette Valley Vineyards Inc.
Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.